Skip to main content

Dbv Technologies ADR(DBVT-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

DBV Technologies Announces Positive Topline Results from Phase 3 EPITOPE Trial of Viaskin Peanut in Peanut-Allergic Toddlers

Globe Newswire - Tue Jun 7, 2022

Montrouge, France, June 7, 2022

DBVTechnologies Announces Positive Topline Results fromPhase 3 EPITOPE Trial of Viaskin Peanut in Peanut-Allergic Toddlers

Read more at globenewswire.com

Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe

watchlist
25 stocks most added to Watchlists